Navigation Links
Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague”
Date:1/14/2014

Rochester, NY (PRWEB) January 14, 2014

During the 1600’s through the 1800’s doctors contributed unknowingly to what is now known as “The Doctor’s Plague.” In this time period, doctors did not know that they needed to wash their hands. This led, at times, to the death of vulnerable patients. In the same way, medical interns and hospital staff today don’t know that they may be unwittingly transmitting herpes viruses to their patients. The CBCD explains.

A study showed that severe fatigue contributed to latent herpes virus reactivation in modern medical interns. The reactivated virus was then transmitted unknowingly to patients as medical interns made their rounds. The study was published on November 9, 2011 in the journal of Interdisciplinary Perspectives on Infectious Diseases (2).

Study authors wrote that “Chronic exposure to complex cognitive and noncognitive stressors (during medical residency) can progress to distress (and) leads to general fatigue (which) has been shown to alter immune responsiveness and (lead to) reactivation of the latent herpes viruses… (2).” In other words, medical interns are exposed to situations that cause extreme fatigue. This fatigue weakens the immune system, which in turn, reactivates the latent herpes virus.

“Physicians, especially those in training, typically work long hours and are often fatigued due to sleep deprivation; fatigue contributes to the human component of medical errors and, thus, jeopardizes patient safety. Decrease in cognitive function was observed among Ob/Gyn residents and medical students … (2).” Moreover, study authors wrote that in these medical interns, “We have detected reactivation of latent herpes viruses that suggests immune suppression (2).”

Reactivation of latent herpes viruses in medical interns places patients at risk. As the study notes, “Fatigue among residents and increased shedding of herpes virus DNA are the major findings of this study. Our subjects have daily close contact with patients in a tertiary care hospital and rotate between intensive care units, operating rooms, the emergency department, inpatient floors, and outpatient clinics. These patients often have a weakened immune system. Increased shedding of viruses by fatigue stressed residents contributes to an unfavorable epidemiological environment (2).”

The CBCD therefore recommends that doctors, medical interns, and hospital administrators learn about Gene-Eden-VIR, a natural product that was tested by scientists at the Center and was proven to reduce symptoms of a herpes infection.

“Control the latent virus and keep it from reactivating can help protect patients. We believe that medical interns and their supervisors owe it to themselves, and to their patients, to become familiar with our research.” – Greg Bennett, CBCD

A clinical study, conducted by scientists at the Center for the Biology of Chronic Disease, and which followed the FDA guidelines for clinical studies, showed that the natural supplement, Gene-Eden-VIR safely and effectively decreases the feeling of fatigue in treated individuals. Specifically, the study found that the natural antiviral product decreased the feeling of general fatigue, the feeling of physical fatigue, and the feeling of mental fatigue (3). The abstract of the study was posted on the Center for the Biology of Chronic Disease website on December 28, 2013 ahead of publication.

To learn more about the CBCD’s research on fatigue, visit http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.

References:

(1)    WebMD - Common Symptoms of Genital Herpes. Last Reviewed on December 24, 2013.
http://www.webmd.com/genital-herpes/guide/common-symptoms?page=2

(2) Fatigue in medical residents leads to reactivation of herpes virus latency. Published on November 9, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/22229027

(3) Gene-Eden-VIR is Effective Against Fatigue: Results of a Post Marketing Clinical Study Conducted According to the FDA Guidelines. Page last updated on December 27, 2013.
        http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11483359.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Risk of Acquiring Genital Warts in the Mouth from Sex is 50%; polyDNA Recommends Targeting Latent HPV with Gene-Eden-VIR
2. Study: RSV often milder than flu in older adults
3. Study: Latent Viruses Change Cells in the Human Body; the Study Supports the Link between Latent Viruses and Disease
4. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
5. Technical Study: Gilead Sciences Inc., Halozyme Therapeutics Inc., NPS Pharmaceuticals Inc., and InterMune Inc.
6. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
7. Study: FOLFIRINOX Followed by Chemoradiation Shows Substantial Activity in Locally Advanced Pancreatic Cancer
8. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
9. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
10. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
11. Nature Materials study: Boosting heat transfer with nanoglue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... , May 18, 2016 The ... it does not mean that there are no opportunities ahead. ... Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics Inc. ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ). ... alerts at: http://www.activewallst.com/ Threshold ...
(Date:5/18/2016)... ... May 18, 2016 , ... Ryan Benton was diagnosed with Duchenne ... the late teens to early twenties. DMD is a relatively common progressive genetic disorder, ... of 22, Benton’s condition was critical. He met with the founder of the ...
(Date:5/17/2016)... ... May 17, 2016 , ... ... Conference that they will collaborate to bring a feeding cup to market based ... Dentistry, and the Craniofacial Center at Seattle Children’s Hospital, thereby ensuring an innovative ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/21/2016)... 22, 2016 Unique technology ... for superior security   Xura, ... of secure digital communications services, today announced it is ... offer enterprise customers, particularly those in the Financial Services ... voice authentication within a mobile app, alongside, and in ...
(Date:3/14/2016)... , March 14, 2016 NXTD ) ... mobile commerce market, announces the airing of a new series ... the week of March 21 st .  The commercials will ... its popular Squawk on the Street show. --> ... the growing mobile commerce market, announces the airing of a ...
Breaking Biology News(10 mins):